From Cholesterol to Dyslipidemia: Why the Dyslipidemia Guideline Had to Change | Episode 1

The 2026 Multi-Society Dyslipidemia Guideline introduced significant changes; but, this episode isn't just about what's new. It's about why the field decided a change was necessary in the first place. In the first installment of this four-part CME/CE-accredited series, host Dave Dixon, PharmD, CLS, FNLA sits down with NLA President Dinesh Kalra, MD, FNLA and Salim Virani, MD to unpack the foundational shift from cholesterol-focused care to a broader dyslipidemia paradigm. The conversati...